Structure and mechanism of sulfofructose transaldolase, a key enzyme in sulfoquinovose metabolism.
Schiff-base
aldolase
cryo-EM
enzyme mechanism
metabolism
sulfonate
sulfoquinovose
sulfur cycle
transaldolase
Journal
Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697
Informations de publication
Date de publication:
02 03 2023
02 03 2023
Historique:
received:
25
10
2022
revised:
15
12
2022
accepted:
25
01
2023
pubmed:
23
2
2023
medline:
8
3
2023
entrez:
22
2
2023
Statut:
ppublish
Résumé
Sulfoquinovose (SQ) is a key component of plant sulfolipids (sulfoquinovosyl diacylglycerols) and a major environmental reservoir of biological sulfur. Breakdown of SQ is achieved by bacteria through the pathways of sulfoglycolysis. The sulfoglycolytic sulfofructose transaldolase (sulfo-SFT) pathway is used by gut-resident firmicutes and soil saprophytes. After isomerization of SQ to sulfofructose (SF), the namesake enzyme catalyzes the transaldol reaction of SF transferring dihydroxyacetone to 3C/4C acceptors to give sulfolactaldehyde and fructose-6-phosphate or sedoheptulose-7-phosphate. We report the 3D cryo-EM structure of SF transaldolase from Bacillus megaterium in apo and ligand bound forms, revealing a decameric structure formed from two pentameric rings of the protomer. We demonstrate a covalent "Schiff base" intermediate formed by reaction of SF with Lys89 within a conserved Asp-Lys-Glu catalytic triad and defined by an Arg-Trp-Arg sulfonate recognition triad. The structural characterization of the signature enzyme of the sulfo-SFT pathway provides key insights into molecular recognition of the sulfonate group of sulfosugars.
Identifiants
pubmed: 36805128
pii: S0969-2126(23)00031-X
doi: 10.1016/j.str.2023.01.010
pii:
doi:
Substances chimiques
Transaldolase
EC 2.2.1.2
sulfoquinovose
3458-06-8
Fructose-Bisphosphate Aldolase
EC 4.1.2.13
Methylglucosides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
244-252.e4Subventions
Organisme : Medical Research Council
ID : MR/T040742/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/W003805/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206161/Z/17/Z
Pays : United Kingdom
Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.